Overview
- Costco said it will not seek certification to dispense mifepristone, attributing the decision to low member demand.
- The retailer had not previously offered the drug, so the announcement maintains its existing pharmacy practice.
- Conservative religious and investor groups that urged retailers to avoid stocking mifepristone, including Alliance Defending Freedom and Inspire Investing, praised Costco and signaled campaigns aimed at other chains.
- CVS and Walgreens state they will continue to dispense mifepristone where permitted under FDA rules.
- Democrats and abortion-rights advocates criticized Costco’s stance, with Sen. Patty Murray calling for the company to reverse course.